Document is current

Any future updates will be listed below

Evaluation of fruquintinib’s efficacy and safety in refractory metastatic colorectal cancer: a systematic review and meta-analysis of phase II and III randomized controlled trials

Crossref DOI link: https://doi.org/10.1007/s12328-024-02087-7

Published Online: 2024-12-20

Published Print: 2025-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark